The Areola study: design and rationale of a cohort study on long-term health outcomes in women with implant-based breast reconstructions.

BACKGROUND Implant-based breast reconstructions contribute considerably to the quality of life of breast cancer patients. A knowledge gap exists concerning the potential role of silicone breast implants in the development of so called 'breast implant illness' and autoimmune diseases in breast cancer survivors with implant-based reconstructions. Breast implant illness (BII) is a constellation of non-specific symptoms reported by a small group of women with silicone breast implants. METHODS/DESIGN The Areola study is a multi-centre retrospective cohort study with prospective follow-up aiming to assess the risk of BII and autoimmune diseases in female breast cancer survivors with and without silicone breast implants. In this report, we set out the rationale, study design and methodology of this cohort study. The cohort consists of breast cancer survivors who received surgical treatment with implant-based reconstruction in six major hospitals across the Netherlands in the period between 2000 and 2015. As comparison group, a frequency-matched sample of breast cancer survivors without breast implants will be selected. An additional group of women who received breast augmentation surgery in the same years will be selected to compare their characteristics and health outcomes with those of breast cancer patients with implants. All women still alive will be invited to complete a web-based questionnaire covering health-related topics. The entire cohort including deceased women will be linked to population-based databases of Statistics Netherlands. These include a registry of hospital diagnostic codes, a medicines prescription registry and a cause-of-death registry, through which diagnoses of autoimmune diseases will be identified. Outcomes of interest are the prevalence and incidence of BII and autoimmune diseases. In addition, risk factors for the development of BII and autoimmune disorders will be assessed among women with implants. DISCUSSION The Areola study will contribute to the availability of reliable information on the risks of BII and autoimmune diseases in Dutch breast cancer survivors with silicone breast implants. This will inform breast cancer survivors and aid future breast cancer patients and their treating physicians to make informed decisions about reconstructive strategies after mastectomy. REGISTRATION This study is registered at ClinicalTrials.gov on June 2nd 2022 (NCT05400954).

[1]  A. Klassen,et al.  Understanding Breast Implant–Associated Illness: A Delphi Survey Defining Most Frequently Associated Symptoms , 2022, Plastic and reconstructive surgery.

[2]  F. V. van Leeuwen,et al.  [Silicone breast implants: the importance of nuanced reporting]. , 2022, Nederlandsch tijdschrift voor geneeskunde.

[3]  M. Hudson,et al.  Risk of rheumatic disease in breast implant users: a qualitative systematic review. , 2021, Gland surgery.

[4]  Rod J. Rohrich,et al.  Breast implant illness: a topic in review. , 2020, Gland surgery.

[5]  U. Makris,et al.  Association of Breast Implants with Nonspecific Symptoms, Connective Tissue Diseases, and Allergic Reactions: A Retrospective Cohort Analysis , 2020, Plastic and reconstructive surgery.

[6]  R. R. van der Hulst,et al.  The Prevalence of Self-Reported Health Complaints and Health-Related Quality of Life in Women With Breast Implants , 2020, Aesthetic surgery journal.

[7]  S. Siesling,et al.  Long-Term Health-Related Quality of Life after Four Common Surgical Treatment Options for Breast Cancer and the Effect of Complications: A Retrospective Patient-Reported Survey among 1871 Patients , 2020, Plastic and reconstructive surgery.

[8]  Kelsey A. Isbester,et al.  Understanding Breast Implant Illness, Before and After Explantation , 2020, Annals of plastic surgery.

[9]  S. Siesling,et al.  The added value of immediate breast reconstruction to health-related quality of life of breast cancer patients. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  R. Tollenaar,et al.  Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands , 2020, Breast Cancer Research and Treatment.

[11]  F. Craig,et al.  Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Current Understanding and Recommendations for Management , 2020, Plastic surgery.

[12]  P. Cordeiro,et al.  Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. , 2020, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[13]  W. Adams,et al.  Breast Implant Illness: A Way Forward , 2019, Plastic and reconstructive surgery.

[14]  J. Selber,et al.  US FDA Breast Implant Postapproval Studies: Long-term Outcomes in 99,993 Patients , 2019, Annals of surgery.

[15]  Shariselle M. W. Pool,et al.  Silicone breast prostheses: A cohort study of complaints, complications, and explantations between 2003 and 2015. , 2018, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[16]  Y. Shoenfeld,et al.  Silicone breast implants and the risk of autoimmune/rheumatic disorders: a real-world analysis. , 2018, International journal of epidemiology.

[17]  J. Dixon,et al.  Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial. , 2018, The Lancet. Oncology.

[18]  Gordon K. Lee,et al.  Breast Reconstruction Following Breast Cancer Treatment-2018. , 2018, JAMA.

[19]  E. Arkema,et al.  Epidemiology of sarcoidosis: current findings and future directions , 2018, Therapeutic advances in chronic disease.

[20]  Hester F. Lingsma,et al.  Patient reported outcome measures in breast cancer patients. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  H. Panchal,et al.  Current Trends in Postmastectomy Breast Reconstruction. , 2017, Plastic and reconstructive surgery.

[22]  J. Reijneveld,et al.  The Use of The Eortc Item Library To Supplement Eortc Quality of Life Instruments , 2017 .

[23]  J. McNeil,et al.  The new opt-out Dutch National Breast Implant Registry - Lessons learnt from the road to implementation. , 2017, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[24]  G. Alarcón,et al.  Epidemiology of systemic lupus erythematosus , 2017, Expert review of clinical immunology.

[25]  Y. Shoenfeld,et al.  The ASIA syndrome: basic concepts , 2017, Mediterranean journal of rheumatology.

[26]  J. C. Cohen Tervaert,et al.  Two hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature , 2016, Immunologic research.

[27]  D. Cromwell,et al.  National trends in immediate and delayed post-mastectomy reconstruction procedures in England: A seven-year population-based cohort study. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[28]  R. Jonsson,et al.  Sjögren syndrome , 2016, Nature Reviews Disease Primers.

[29]  E. Panagopoulou,et al.  A systematic review of the factors predicting the interest in cosmetic plastic surgery , 2016, Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India.

[30]  D. Rietveld,et al.  Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors. , 2016, International journal of radiation oncology, biology, physics.

[31]  M. Carty,et al.  Evolving options for breast reconstruction. , 2015, Current problems in surgery.

[32]  A. Verbeek,et al.  Breast cancer diagnosis and death in the Netherlands: a changing burden. , 2015, European journal of public health.

[33]  Hans Kromhout,et al.  The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses , 2014, BMC Cancer.

[34]  J. C. Cohen Tervaert,et al.  Silicone implant incompatibility syndrome (SIIS): A frequent cause of ASIA (Shoenfeld’s syndrome) , 2013, Immunologic Research.

[35]  P. Hall,et al.  Risk of treatment-related esophageal cancer among breast cancer survivors. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[36]  D. Parkin,et al.  16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 , 2011, British Journal of Cancer.

[37]  M. Piccart,et al.  Long-term toxic effects of adjuvant chemotherapy in breast cancer. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[38]  P. Cuijpers,et al.  Quick and easy self-rating of Generalized Anxiety Disorder: Validity of the Dutch web-based GAD-7, GAD-2 and GAD-SI , 2011, Psychiatry Research.

[39]  J. Gran,et al.  The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients , 2011, Annals of the rheumatic diseases.

[40]  R. Meijer,et al.  Health-care costing in the Netherlands , 2010, BMC Health Services Research.

[41]  A. Beekman,et al.  Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics , 2010, BMC health services research.

[42]  F. Wolfe,et al.  The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity , 2010, Arthritis care & research.

[43]  Tore Sørlie,et al.  Psychosocial predictors of an interest in cosmetic surgery among young Norwegian women: a population-based study. , 2010, Plastic and reconstructive surgery.

[44]  Y. Shoenfeld,et al.  Adjuvants and autoimmunity , 2009, Lupus.

[45]  P. Cordeiro,et al.  Development of a New Patient-Reported Outcome Measure for Breast Surgery: The BREAST-Q , 2009, Plastic and reconstructive surgery.

[46]  F. Mols,et al.  Normative data of the SF-12 health survey with validation using postmyocardial infarction patients in the Dutch population , 2009, Quality of Life Research.

[47]  J. V. van Laar,et al.  Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study , 2008, Annals of the rheumatic diseases.

[48]  M. Petri,et al.  Chapter 2 Epidemiology of the Antiphospholipid Syndrome , 2009 .

[49]  G. Nahler.  anatomical therapeutic chemical classification system (ATC) , 2009 .

[50]  D. de Jong,et al.  Anaplastic large-cell lymphoma in women with breast implants. , 2008, JAMA.

[51]  M. Hernán,et al.  Temporal trends in the incidence of multiple sclerosis , 2008, Neurology.

[52]  Y. Rosseel,et al.  Psychometric Properties of the Dutch Rosenberg Self-Esteem Scale , 2008 .

[53]  Patrick Monahan,et al.  Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection , 2007, Annals of Internal Medicine.

[54]  M. Muller,et al.  Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. , 2006, Journal of the National Cancer Institute.

[55]  G. V. van Heck,et al.  Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). , 2004, British journal of health psychology.

[56]  Klaas Sijtsma,et al.  Examination of the Dimensionality of Fatigue , 2004 .

[57]  R. Spitzer,et al.  The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener , 2003, Medical care.

[58]  D. Dush,et al.  Breast implants and illness: a model of psychological factors , 2001, Annals of the rheumatic diseases.

[59]  L. Signorello,et al.  Self-reported symptoms among women after cosmetic breast implant and breast reduction surgery. , 2001, Plastic and reconstructive surgery.

[60]  E. Weiderpass,et al.  Characteristics of Women With Cosmetic Breast Augmentation Surgery Compared With Breast Reduction Surgery Patients and Women in the General Population of Sweden , 2000, Annals of plastic surgery.

[61]  L. Kupper,et al.  Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. , 2000, The New England journal of medicine.

[62]  F. Wolfe,et al.  "Silicone related symptoms" are common in patients with fibromyalgia: no evidence for a new disease. , 1999, The Journal of rheumatology.

[63]  J H Lubin,et al.  Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. , 1999, American journal of epidemiology.

[64]  K. Kern,et al.  Carcinogenic potential of silicone breast implants: a Connecticut statewide study. , 1997, Plastic and reconstructive surgery.

[65]  D. Ibañez,et al.  An Outcome Analysis of 100 Women After Explantation of Silicone Gel Breast Implants , 1997, Annals of plastic surgery.

[66]  D. Brogan,et al.  Characteristics of women with and without breast augmentation. , 1997, JAMA.

[67]  J. Manson,et al.  Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. , 1996, JAMA.

[68]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[69]  J Benichou,et al.  Proportion of breast cancer cases in the United States explained by well-established risk factors. , 1995, Journal of the National Cancer Institute.

[70]  J. Coebergh,et al.  Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. , 1995, European journal of cancer.

[71]  H. Adami,et al.  Silicone breast implants and risk of cancer? , 1995, JAMA.

[72]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[73]  K.,et al.  Do Implanted Medical Devices Cause Cancer? , 1994, Journal of biomaterials applications.

[74]  E. Giltay,et al.  Silicone breast prostheses and rheumatic symptoms: a retrospective follow up study. , 1994, Annals of the rheumatic diseases.

[75]  D. Albert,et al.  Connective-tissue disease following breast augmentation: a preliminary test of the human adjuvant disease hypothesis. , 1988, Plastic and reconstructive surgery.

[76]  D. Laub,et al.  Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. , 1986, Plastic and reconstructive surgery.

[77]  M. Pike,et al.  The Relationship Between Breast Cancer and Augmentation Mammaplasty: An Epidemiologic Study , 1986, Plastic and reconstructive surgery.